Fucosyltransferase 4 upregulates P-gp expression for chemoresistance via NF-κB signaling pathway

Zixuan Cai1, Tomoya Isaji2, Caixia Liang3

  • 1Division of Regulatory Glycobiology, Graduate School of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Japan.

Abstract

Insights

FUT4 upregulation increases chemoresistance by enhancing P-glycoprotein via the NF-κB pathway. Targeting FUT4 may overcome multidrug resistance in cancer therapy.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Multidrug resistance (MDR) is a major challenge in chemotherapy.
  • N-acetylglucosaminyltransferase III (GnT-III) negatively regulates chemoresistance.
  • Increased fucosylation was observed in adriamycin-resistant (ADR) cells.

Purpose of the Study:

  • To investigate the role of fucosylation, specifically FUT4, in adriamycin resistance (ADR).
  • To elucidate the mechanism by which FUT4 influences chemoresistance.
  • To evaluate FUT4 as a potential therapeutic target for MDR.

Main Methods:

  • Lectin blot, western blot, and flow cytometry for fucosylation analysis.
  • Quantitative PCR (qPCR) for gene expression.
  • CRISPR/Cas9 to generate FUT4 knockout (KO) ADR cells.
  • Cytotoxicity and drug efflux assays.

Main Results:

  • FUT4 and LeX antigen expression were upregulated in ADR cells.
  • FUT4 KO reduced P-glycoprotein (P-gp) levels and increased drug sensitivity.
  • Restoring FUT4 reversed P-gp expression, drug efflux, and chemoresistance.
  • FUT4 modulated NF-κB pathway signaling, specifically p65 phosphorylation.

Conclusions:

  • FUT4 promotes chemoresistance by upregulating P-gp expression through the NF-κB signaling pathway.
  • FUT4 is a key regulator of chemoresistance in ADR cells.
  • FUT4 represents a promising therapeutic target for overcoming MDR.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.2K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
254
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K